Tuberculosis Patients Can Reduce Transmissability By Inhaling Interferon Through A Nebulizer, NYU Langone Medical Center Study

Bookmark and Share

NYU Langone Medical Center -- A new study published in the September 15, 2009, issue of PLoS ONE found that patients with cavitary pulmonary tuberculosis receiving anti-TB medications supplemented with nebulized interferon-gamma have fewer bacilli in the lungs and less inflammation, thereby reducing the transmissibility of tuberculosis in the early phase of treatment.

Back to news